BSE filing, NSE: HAL. Summary written from the filing by ALFA Finder's alert engine.
Hindustan Aeronautics Ltd: key numbers
- Share price
- ₹4,850.00
- Market cap
- ₹3,24,356 Cr
- Revenue (annual)
- ₹33,089 Cr
- Net profit (annual)
- ₹9,116 Cr
- P/E (TTM)
- 34.8×Sector 52.0×
- Promoter holding
- 71.64%+0.00% QoQ
- FII holding
- 9.42%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hindustan Aeronautics Ltd
All →Hindustan Aeronautics Board Meeting Date
Hindustan Aeronautics will hold a board meeting on 12 November 2026 to consider H1 results. Trading window stays closed until 14 November 2026.
Hindustan Aeronautics Management Change
HAL corrects Shri Anindya Biswas's designation in its earlier Board Meeting outcome. His title should read DS & DG (Aero), not DS & Director RCI.
Hindustan Aeronautics Other Announcement
Hindustan Aeronautics Limited has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with Regulation 31(1)(b) of the LODR.
Hindustan Aeronautics Management Change
HAL appointed Shri Anindya Biswas of DRDO as Government Nominee Director, replacing Dr. K Rajalakshmi Menon w.e.f. 7 October 2026. The change is subject to shareholder approval.
Hindustan Aeronautics Acquisition
Hindustan Aeronautics Ltd (HAL) has agreed to acquire the remaining 50% stake in HATSOFF Helicopter Training Pvt. Ltd. from CAE, Canada, for nil consideration.
Hindustan Aeronautics Management Change
Hindustan Aeronautics Ltd announced the superannuation of Shri R Sriram, Executive Director (Finance). He will step down from his position effective September 30, 2026.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.